Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia in vitro

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number1286863
JournalFrontiers in Oncology
Volume13
DOIs
StatePublished - Nov 7 2023

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • AML
  • BAD
  • Bcl-2
  • CD44
  • JAK/STAT
  • compensation
  • homeostasis
  • tyrosine kinase inhibitor

Cite this